Ocular Pigmentation Protects the Rabbit Retina From Gentamicin-Induced Toxicity

Size: px
Start display at page:

Download "Ocular Pigmentation Protects the Rabbit Retina From Gentamicin-Induced Toxicity"

Transcription

1 Ocular Pigmentation Protects the Rabbit Retina From Gentamicin-Induced oxicity Esther Zemel* Anat Loewenstein,"f Bo Lei* Moshe Lazar,\ and Ido Perlman* Purpose. his study was designed to investigate the possibility that gentamicin-induced retinal toxicity is dependent on ocular pigmentation by comparing the effects of the drug on the functional and morphologic integrity of the retina in albino and pigmented rabbits. Methods. In each rabbit, a solution of gentamicin sulfate was injected into the vitreous of one eye, and saline was injected into the other eye. Retinal function was assessed by electroretinogram (ERG) at different time intervals after injection. Retinal structure was examined at the light microscopic level. Results. In albino and pigmented rabbits, functional retinal damage developed to a maximal level within the first week after gentamicin injection. hereafter, gradual recovery could be seen in eyes that suffered less than 80% maximal reduction in the ERG b-wave. For each dose >0.1 mg studied, retinal damage was more severe in the albino rabbits than in the pigmented ones. he degree of damage was not affected by the level of ambient illumination, nor was it reduced by the administration of N-acetylcystein, a free radical scavenger, together with gentamicin. Conclusions. Ocular pigmentation partially protects the rabbit retina from the toxic action of gentamicin. his protection probably reflects binding of the drug by the melanin, which thereby reduces the concentration of the free gentamicin. When the initial gentamicin-induced retinal damage is expressed in <80% reduction in the ERG, substantial recovery may occur in both strains of rabbits. Invest Ophthalmol Vis Sci. 1995;36: Oecause of their effectiveness against gram-negative and gram-positive bacteria, 1 aminoglycosides are the preferred antibiotics for the treatment and prophylaxis of ocular infections. However, the use of these antibiotics has been limited by their well-documented toxicity to the retina. Numerous studies have been conducted on different animal species to determine the safe, nontoxic dosage of gentamicin for intravitreal injection. A wide range of "safe" dose has been reported that partially could be accounted for by species differences. However, even in the same species, different results were obtained. In one study on albino rabbits, retinal damage was detected when gentamicin in a dose as low as 0.03 mg was injected with the bevel of the needle From the *he Bruce, linppnport Faculty of Medicine, echnion Israel Institute of echnology, and llie Rappaport Institute for Research in the Medical Sciences, Haifa; and the f Department of Ophthalmology, Ichilov Hospital, el-aviv, Israel. Sulnnilled for publication December 28, 1994; revised February 27, 1995; accepted April II, Proprietary interest category: N. Reprint requests: Ido Perlman, he Bruce Rappaport Faculty of Medicine, echnion-israel Institute of echnology, P.O. Box 9649, Haifa 31096, Israel. pointing to the retina, whereas a dose of 0.2 mg was not harmful when the bevel was pointed toward the anterior chamber. 2 A second study on the same animal species reported that a dose of 0.08 mg gentamicin produced functional retinal damage as evidenced by electrophysiological recordings. 3 In pigmented rabbits, a dose of 0.2 mg of gentamicin was found to be toxic based on electrophysiology and light microscopy. 4 In another study, a dose of 0.5 mg was found to cause structural damage, 5 but it was reported to be safe in a third study.' 1 Others found damage only when a dose of at least 0.8 mg was used. 78 Research conducted in monkeys found 0.4 mg gentamicin to be safe to the retina, as judged by ophthalmoscopy, electrophysiological testing, and light and electron microscopic criteria, 9 whereas others found doses of gentamicin from 1.0 to 10.0 mg to be toxic. 10 " 12 he wide diversity of results in these animal studies did not allow accurate determination of a safe dose for intravitreal injection of gentamicin in human patients. Moreover, species differences may cause a certain dose to be safe in one animal but toxic in another. Investigative Ophthalmology & Visual Science, August 1995, Vol. 36, No. 9 Copyright Association for Research in Vision and Ophthalmology 1875

2 1876 Investigative Ophthalmology & Visual Science, August 1995, Vol. 36, No. 9 In fact, many incidences of retinal toxicity in humans after the injection of supposedly safe doses are still being reported. 13 ""' It is now obvious that although most patients can tolerate an intra vitreous dose of 0.1 mg of gentamicin sulfate, there may be specific, yet unidentified, characteristics of the eyes of some patients that make them susceptible to injury at this low dose level. 16 he cause of varying thresholds of gentamicin toxicity emerging from animal studies is most probably multifactorial. he facile explanation of species differences will not suffice because wide ranges of allegedly safe doses have been reported in studies of the same animal species. 3 " 8 hus, other variables must be considered. he clinical factors involve the surgical state of the eye, 17 the presence and severity of infection, 8 and the position of the needle bevel. 2 In the animal studies, most of these factors are well controlled so that only those physiological variables that may either augment or reduce gentamicin-induced toxicity need to be considered. he physiological factors include the degree of ocular pigmentation, the level of ambient illumination, room temperature, and stress. Exposure to light, 1819 high temperature, 20 and stress 21 are known to induce retinal damage both by themselves and by augmenting the effects of other retinopathic agents. hey, therefore, also may play a role in gentamicininduced retinal damage. Melanin in the pigment epithelium may play a dual protective role in drug-induced retinopathy. First, it reduces the exposure of the retina to light by absorbing the photons that bypass the photoreceptors. herefore, albino animals are rendered more susceptible to light-induced retinal damage than are pigmented animals. 22 Additionally, melanin is known as a scavenger of free radicals. 23 If gentamicin-induced toxicity is mediated by free radicals, the melanin of the pigment epithelium may provide some protection. he aim of this study was to compare quantitatively the development of gentamicin-induced retinal toxicity between albino and pigmented rabbits to determine the role of ocular pigmentation in this pathologic process. MEHODS Animals Fifty-two albino and 30 pigmented rabbits weighing 1.5 to 3.2 kg each were used in this study. Each experiment was performed in parallel on a similar number of albino and pigmented rabbits of similar weights to minimize the variability in gentamicin toxicity unrelated to ocular pigmentation. he animals were housed in separate cages under 12-hour light-12-hour dark cycles in the Animal Facility of the Faculty of Medicine, echnion-israel Institute of echnology (Haifa, Israel). After the intravitreal injections, most of the animals were returned to the same room on a 12-hour light-12-hour dark cycle. One experimental group of eight albino rabbits was placed in total darkness for 1 week after gentamicin injection to test for a possible interaction between ambient illumination and gentamicin toxicity. All experimental procedures conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Procedure he animals were anesthetized by an intramuscular injection (0.5 ml/kg body weight) of a "cocktail" prepared in the following proportions: 1 ml Ketalar (Parke-Davis, Gwent, UK), 0.2 ml acepromazine maleate, and 0.3 ml xylazine. he pupils were fully dilated with cyclopentolate hydrochloride 1%. opical anesthesia (benoxinate HCL 0.4%) was administered before carrying out electroretinogram (ERG) recordings and before intravitreal injection. he ERG was used to estimate the functional integrity of the retina. he test was performed at different time intervals after intravitreal injection of the drug. After the last elecrophysiological recording session, eyes were enucleated and prepared for histology, and the rabbits were killed by an overdose of sodium pentobarbital. Drugs Gentamicin sulphate (eva, Jerusalem, Israel) at a concentration of 40 mg/ml was used. It was diluted as necessary with physiological saline to produce the desired concentrations. he most concentrated gentamicin solution used in this study (10 mg/ml) had an osmolarity of 255 mosm and a ph of 4.3. N-acetylcystein (Sigma, St. Louis, MO) was used as an antioxidant to test for possible involvement of free radicals in gentamicin toxicity. 24 ' 25 Intravitreal Injection All intravitreal injections were administered as described 26 with a 25-gauge needle using a 1.0-ml tuberculine syringe. he needle was introduced 3 mm posterior to the limbus under visual control by means of an indirect ophthalmoscope and was advanced toward the region of the optic disk as close to the retina as possible. In every rabbit, a volume of 0.1 ml of drug solution was injected into the experimental eye while a similar volume of saline was injected into the fellow, control eye. he injection was carried out with the bevel of the needle pointing away from the retina to prevent any damage to the retina. Electroretinogram he ERG responses were recorded simultaneously from the experimental and control eyes with corneal

3 Gentamicin-Induced Retinal oxicity 1877 electrodes (Medical Workshop, Groningen, Holland) as described. 2 ' 1 he reference and ground electrodes were inserted into the ears. he ERG signals were amplified by a factor of 20,000 and filtered (0.3 to 300 Hz) by differential amplifiers (P511; Grass, Quincy, MA). he output of each amplifier was digitized at a rate of 2 khz (Lab-Master; Scientific Solutions, Encino, CA) and stored in a 386 computer for off-line analysis. Light stimuli were obtained from one of two sources. A xenon photostimulator (PS22; Grass) was used to elicit the ERG responses in the light-adapted state (background illumination of 11 foot lamberts). he intensity of this light source was controlled by the instrument settings (II to 116). he dark-adapted ERG responses were evoked by an electronic camera flash that could be attenuated by a set of neutral-density filters covering a range of 5 log units. Electroretinographic analysis was based on amplitude measurements of the b-waves. It was measured from the trough of the a-wave to the peak of the b- wave. For each rabbit in each ERG recording session, the b-waves of the experimental eye were divided by the corresponding values recorded from the control eyes. he mean b-wave ratio (experimental eye/control eye) was used as an index for retinal function in the experimental eye. 2t> Histology he eye was soaked for 10 minutes in 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer (ph 7.4). It was slit 2 mm posterior to the limbus to facilitate fixation. After 72 hours, the anterior segment of the eye was removed by a circumferential incision 2 mm posterior to the limbus. After removal of the vitreous, the posterior eyecup was bisected at the level of the optic disk. One half of each eyecup was rinsed in water and then dehydrated twice in 70% alcohol for 3 hours and twice in 96% alcohol for another 3 hours. Embedding was performed in a JB-4 resin (Bio-Rad, Watford, England). issue sections were cut by a Reichert Jung microtome at a thickness of 2 /Ltm and mounted onto slides. For light microscopy, the sections were stained with Richardson's stain. In a previous study, 27 we showed that small volumes of drugs injected into the vitreous might produce only localized structural effects. herefore, two loci were always inspected for each rabbit one close to the site of injection and the other approximately 15 mm more peripherally. RESULS he effects of 1.0 mg gentamicin on representative ERG responses of one albino and one pigmented rab- Albino Rabbit A (A) Light-adapted >A 116 *Vi A.V.-ZH-'-V J J V K H.: -3.0 \ -1.0 i \ l (B) Dark-adapted Pigmented Rabbit *\s*^ v»k FIGURE l. he effects of 1.0 mg gentamicin on the light- and dark-adapted electroretinographic responses as measured 1 week after intravitreal injection in one albino and one pigmented rabbit. Each pair of traces represents the responses recorded from the left, control eye (upper trace) and the right, experimental eye (lower trace). Stimulus intensity is given as the setting of the Grass photostimulator for the light-adapted responses and in stimulus attenuation (density of neutral filter) for the dark-adapted responses. Calibration bars: vertical, 100 /xv; horizontal, 100 msec. bit are compared in Figure 1. he responses were recorded 1 week after injection of the drug to the experimental right eye (lower traces) and of saline to the control left eye (upper traces). he ERG recordings demonstrate a severe functional deficit of the experimental retina in the light- and dark-adapted states in both animals. However, the reduction of the ERG amplitude is more pronounced in the albino than in the pigmented rabbit. his is most evident in the responses elicited in the dark-adapted state by the brightest light stimuli (bottom part of the figure). o assess the functional damage to the retina in a quantitative manner, the b-wave ratio was defined. 2 ' 1 th i

4 1878 Investigative Ophthalmology 8c Visual Science, August 1995, Vol. 36, No. 9 A FIGURE 2. Gentamicin-induced structural damage to the albino rabbit retina. he eyes were prepared for histology 2 weeks after injection of 1.0 mg gentamicin. Light micrographs from the experimental retina (C,D) are compared to corresponding areas from the control retina injected with saline solution (A,B). he micrographs were taken from the site of injection (A,C) and from a remote (15 mm from the optic disk) site (B,D). Calibration bar: 50 /im. For each stimulus intensity, the amplitude of the bwave recorded from the experimental eye was divided by the corresponding value recorded from the control eye. hese ratios were averaged to give die light- and dark-adapted b-wave ratios. For the two rabbits whose ERG responses are shown in Figure 1, the mean (± SD) of the light- and dark-adapted b-wave ratios were 0.16 ± 0.09 and 0.12 ± 0.08 for the albino rabbit and 0.33 ± 0.12 and 0.35 ± 0.15 for the pigmented rabbit. hus, the effect of 1.0 mg gentamicin was more pronounced in the albino rabbit retina. he functional loss induced by a dose of 1.0 mg gentamicin was supported by histologic observations as demonstrated for an albino rabbit in Figure 2. he eyes of this rabbit were enucleated 2 weeks after the injection of gentamicin, and both retinas were prepared for light microscopy. Micrographs of die experimental and control retinas, obtained from similar loci relative to the site of injection, were compared. he retina of the control eye injected with saline solution appeared unharmed in both loci; one was adjacent to die site of injection (Fig. 2A) and the other was more peripheral (15 mm from die optic disk) (Fig. 2B). he micrographs that had been obtained from the experimental retina exhibited severe damage at the site of injection (Fig. 2C) and more peripherally (15 mm away from the optic disk) (Fig. 2D). According to these micrographs, gentamicin-induced structural damage seemed to be restricted to the outer retina. It was manifested by an almost complete loss of inner and outer segments of the photoreceptors, whereas the outer nuclear layer and die inner layers of the retina appeared normal. he mean (± SD) light- and dark-adapted b-wave ratios of diis rabbit were 0.20 ± 0.05 and 0.10 ± 0.05, respectively. o estimate the safe dose of gentamicin, specifically the maximal dose that would not produce functional or structural retinal damage, or both, to the albino and pigmented rabbits, solutions containing different concentrations of die drug were injected intravitreally. heir toxic action was assessed from the b-wave ratios of the ERG responses 1 week after injec-

5 Gentamicin-Induced Retinal oxicity I D Albino 0 Pigmcnlcd GENAMICIN DOSE (mg) K D Albino 0 Pigmcnlcd I I GENAMICIN DOSK (mg) z^**w '/S'i'K FIGURE 3. he effects of different gentamicin doses on the electroretinogram (ERG) responses of albino and pigmented rabbits as determined 1 week after intravitreal injection. he mean (± SD) of the light-adapted (upper part) and dark-adapted (lower part) b-wave ratios are given for each dose. he size of each experimental group is indicated in the bars. Each ERG ratio that was significandy (P < 0.05) different between the two groups of rabbits is denoted by an asterisk. tion. hese data are summarized in Figure 3. he mean (± SD) values of the light-adapted b-wave ratios (upper part, Fig. 3) and of the dark-adapted b-wave ratios (lower part, Fig. 3) are given for four different doses of gentamicin sulfate: 0.1 mg, 0.3 mg, 0.6 mg, and 1.0 mg. In preliminary experiments, the b-wave ratios (right eye:left eye) were calculated for 25 untreated albino rabbits. Mean (± SD) values of 1.1 ± 0.24 and 0.99 ±0.16 were obtained for the light- and dark-adapted states, respectively. hese control data describe the interocular variability of the b-wave amplitudes and are independent on ocular pigmentation. hey depend only on the normal variability between the two eyes and on technical differences such as electrode placement, lighting conditions, and pupil size. he data of each experimental group were compared to the control group using a Student's West. he b- wave ratios of the albino and pigmented rabbits injected with 0.1 mg gentamicin did not differ from the normal (P > 0.05). In albino rabbits, both the lightand dark-adapted b-wave ratios were significantly (P < 0.05) reduced compared to the normal ratios for all other doses studied (0.3, 0.6, and 1.0 mg). For the pigmented rabbits, only doses of 0.6 and 1.0 mg gentamicin produced significant (P< 0.05) reduction of the light- and dark- adapted b-wave ratios. he data in Figure 3 indicate that the b-wave ratio was higher in the pigmented rabbits than in the albino rabbits for every dose of gentamicin studied. he differences were tested for statistical significance, and a significant (P < 0.05) difference between the b-wave ratios of albino versus pigmented rabbits was obtained for two doses, 0.3 mg and 1.0 mg (denoted by the asterisks above the bars, Fig. 3). he dose of 0.1 mg gentamicin did not cause any apparent ERG deficit in either albino or pigmented rabbits, whereas the damage caused by 0.6 mg gentamicin was more severe in albino than in pigmented rabbits. his difference, however, was not statistically significant. hese data indicate that the safe dose of gentamicin is higher for pigmented rabbits than for albino rabbits as determined electroretinographically 1 week after injection. It was demonstrated that synthetic melanin markedly reduced the activity of aminoglycosides by binding of the antibiotic. 28 hus, injected gentamicin may remain longer in the pigmented eye than in the albino eye. If so, gentamicin-induced toxicity to the pigmented rabbit retina, even though lower initially, may develop slowly over a longer period of time to reach a level similar or even greater than that seen in the albino eye. o investigate this possibility, we performed eight consecutive ERG recordings at different time intervals after the injection of 0.6 mg gentamicin in four albino and four pigmented rabbits. he first ERG recording was performed 1 hour after injection, and the last was performed 84 days later. he changes in the mean (± SD) light- and dark-adapted b-wave ratios with time are shown in Figure 4 (open circles, albino rabbits; filled circles, pigmented rabbits). Maximal reduction in retinal function, assessed from the ERG b-wave ratio, was seen 1 to 2 weeks after injection in both groups of rabbits. hereafter, the b-wave ratios in the pigmented rabbits gradually recovered and almost reached the preinjection values within 84 days. he albino rabbits exhibited litde recovery of the darkadapted b-wave ratios and virtually none of the lightadapted b-wave ratios within the follow-up period (84 days). he mean b-wave ratios representing the pigmented rabbits (filled circles) were significantly (P < 0.05) larger than the corresponding values for the albino rabbits (open circles) for every time interval longer than 7 days after injection (Fig. 4, asterisks). he data in Figure 4 indicate that the rabbit retina may recover from the deleterious effects of gentamicin even if severe damage initially is seen. o assess poten-

6 1880 Investigative Ophthalmology & Visual Science, August 1995, Vol. 36, No. 9 tial recovery and its relationship to initial damage, the maximal dark-adapted b-wave ratios, measured 84 days after gentamicin injection, were compared to the minimal values determined 1 week after injection. hese data are summarized in Figure 5 for 10 albino and 10 pigmented rabbits (open and filled circles, respectively) injected with either 0.3, 0.6, or 1.0 mg and tested at least twice (1 and 12 weeks) after injection. If there had been no functional recovery of the retina, all the data points in Figure 5 would have been expected to cluster around the identity line (continuous line). his was not the case. Only seven albino and three pigmented rabbits exhibited permanent severe ERG deficit that did not change appreciably from the measurement conducted 1 week after injection to that measured at the end of the follow-up period (12 weeks after injection). Substantial recovery was observed in seven pigmented and three albino rabbits, and normal b-wave ratios were measured in some of them at the end of the follow-up period. he 10 rabbits that exhibited substantial ERG recovery were characterized by minimal b-wave ratios larger than 0.2 (Fig. 5, dashed vertical line). hese data indicate that the rabbit retina, regardless of ocular pigmentation, may recover from the toxic action of gentamicin provided that the initial effect of the drug measured 1 week after injection is expressed by an ERG reduction <80%. he development of structural damage is illustrated in Figure 6, in which light micrographs of retinas from two albino rabbits injected with 0.6 mg gentamicin are compared. One rabbit was killed 3 weeks after injection (Figs. 6A, 6B), and the other was killed 12 weeks after injection (Figs. 6C, 6D). Micrographs were taken from the site of injection (Figs. 6A, 6C) and more peripherally (15 mm from the optic disk) ime (Days) (Figs. 6B, 6D). In both rabbits, structural damage was similar across the retina and did not vary as a function of the distance from the site of injection. he retina that was prepared 3 weeks after injection was very thin but maintained its organization into alternate layers of cell bodies and synaptic interactions. Few cells were apparent in the outer nuclear layer, and there were no inner or outer segments. his retina was characterized by light- and dark-adapted b-wave ratios of 0.37 ±0.10 and 0.39 ± 0.07, respectively. he retina prepared 12 weeks after injection exhibited more severe anatomic destruction. It had lost its organized structure, and only few unidentified retinal cells could be ime (Days) seen, scattered randomly within the retina. he b-wave FIGURE 4. he time course of gentamicin (0.6 mg)-induced ratios of this retina were 0.13 ± 0.08 and 0.09 ± 0.06 retinal damage in four albino (open circles) and four pig-fomented rabbits {filled circles). he mean (± SD) b-wave ratios the light- and dark-adapted states, respectively. he data described in Figures 1, 3, and 4 indicate for light-adapted (upper part) and dark-adapted (lower part) states are compared between the two groups. Significant (P < 0.05) differences are denoted by asterisks MINIMAL B-WAVE RAIO (7 days) Pigmented O Albino FIGURE 5. he dependency of functional recovery (maximal b-wave ratio) measured 84 days after injection on the initial, maximal damage (minimal b-wave ratio) determined 1 week after injection. Data for 10 albino (open circles) and 10 pigmented rabbits (filled circles) injected intravitreally with different doses of gentamicin are compared. Error bars denote the standard deviation of the b-wave ratio for each rabbit at each electroretinogram (ERG) recording session. he continuous line is the identity line. he dashed vertical line indicates an initial damage of 80% reduction in the ERG responses. 0.8

7 1881 Gentamicin-Induced Retinal oxicity Structural retinal damage in two albino rabbits that underwent permanent electre retinogram deficit after the injection of 0.6 mg gentamicin. he retina of one rabbit was prepared for light microscopy at 3 weeks (A,B), and the retina of the other rabbit was prepared at 12 weeks (C,D) after injection. Light micrographs were obtained from the site of injection (kc)and a more peripheral (15mm from the optic disk) site (C,D).Calibration bar: 50 pm. FlCURE6. that the melanin in the pigment epithelium provides the rabbit retina with some degree of protection against the toxic effects of gentamicin. Melanin may influence gentamicin-induced retinopathy by at least three mechanisms. It absorbs stray light bypassing the photoreceptors thereby reducing the degree of light exposure;22 it is a scavenger of free radicals and may act as an antioxidant;'%d it binds the drug and reduces the concentration of free gentarnicin.'" hese alternatives were tested by comparing the effects of 0.6 mg gentamicin on the ERG in 25 albino rabbits that were divided into three groups, as shown in Figure 7. One group was maintained in a 12-hour light12-hour dark cycle. he second group was kept in total darkness after injection, and the animals in the third group were injected with a mixture of gentamicin and the antioxidant N-acetylcystein. he mean ( 2 SD) light- and dark-adapted b-wave ratios of these groups did not differ statistically. he data shown in Figure 7 suggest that neither the lighting conditions nor the addition of an antioxidant provided any pro- tection to the albino rabbit retina against gentamicininduced damage. It should be mentioned that in preliminary experiments, we found that neither 1 week of darkness nor N-acetylcystein produced any effect on the b-wave ratios (right eye:left eye) of albino rabbits. DISCUSSION hese findings support those of previous reports2-* on the toxic action of gentamicin on the rabbit retina. Functional retinal damage, assessed from the ERG responses, could be detected as early as 3 hours after intravitreal injection of the drug. he degree of functional damage slowly developed with time, reaching a maximal level within 1 to 2 weeks of injection. hereafter, it either stabilized or exhibited slow but progressive recovery. In some of the rabbits, the ERG responses completely recovered to the normal preinjection level within 12 weeks (Fig. 4). here seems to be a clear threshold that separates retinas that can recover from those that suffer from permanent damage (Fig.

8 1882 Investigative Ophthalmology 8c Visual Science, August 1995, Vol. 36, No. 9? I P 0.3 * 0.2 < 0.1 m 0.0 D Light adapted 0 Dark adapted (N=9) (N=8) (N=8) Light/Dark Dark Light/Dark with NAC FIGURE 7. he effect of 0.6 mg gentamicin on the mean (± SD) light- and dark-adapted b-wave ratios of three groups of albino rabbits. One group of rabbits was injected with gentamicin alone and was kept in a 12-hour light-12-hour dark cycle. Rabbits in the second group were injected with a mixture of gentamicin and N-acetylcystein and kept in a 12-hour light-12-hour dark cycle. Rabbits in the third group were injected with gentamicin alone and were kept in complete darkness. he number of animals in each experimental group is denoted in the figure. 5). Eyes that were characterized by more than 80% reduction in the ERG responses (b-wave ratios <0.2) exhibited little recovery, whereas those suffering from less initial damage (b-wave ratio >0.2) exhibited substantial recovery and could attain the preinjection b- wave ratio. he retinas that recovered from the toxic action of gentamicin appeared unharmed at the light microscopic level (data not shown). he observation that the rabbit retina may recover from gentamicininduced damage raises the possibility that some of the variability in the safe dose of gentamicin, determined in different studies, can be accounted for by differences in the experimental protocols used. hus, a dose of gentamicin that leads to a 50% ERG reduction when measured 1 week after injection and that is therefore reported as highly toxic may appear safe if the ERG is measured several weeks later. Morphologic observations indicated that the initial site of gentamicin toxic action was the outer retina. 78 wo weeks after injection, when the physiological effect of gentamicin reached its peak, the inner retina and the outer nuclear layer seemed intact, whereas the inner and outer segments of the photoreceptors were missing (Fig. 2). his type of structural damage is reminiscent of the one induced by hemicholinium-3, a drug that is a competitive inhibitor of choline uptake and that interferes with the outer segment renewal process. 29 Gentamicin also may exert its toxic action by interfering with the synthesis of new outer segment disks. wo cellular processes needed for the production of new outer segment disks, protein synthesis and lipid metabolism, may be the site of action of gentamicin. he aminoglycoside antibiotics are known to act on the bacterial ribosomes, leading to the production of faulty proteins and eventually to death of the microorganism Alternatively, aminoglycoside-induced ototoxicity has been attributed to the interactions of the drug with polyphosphoinositoles. 32 ' 33 Phosphatydilinositol is abundant in the rod outer segment and is needed for synthesis of outer segment disks. 34 ' 35 herefore, interaction of gentamicin with this phospholipid may interfere with the outer segment renewal process. At prolonged periods of time after gentamicin injection, the rabbit retina may exhibit either substantial recovery or permanent functional and structural damage, depending on the degree of initial damage (Fig. 5). When the initial damage is severe (b-wave ratio <0.2), the synthesis of new outer segment disks fails to restore the outer segments, which leads to permanent damage. In these retinas, structural damage, first seen in the outer segments, spread with time to the entire retina (Fig. 6). In retinas experiencing only mild to moderate initial damage (b-wave ratio >0.2), the rate of synthesis of new outer segment disks is probably sufficient to restore the integrity of the photoreceptors. In that case, the retina appears structurally and functionally normal at longer time intervals after injection. We found that the degree of gentamicin-induced functional damage strongly depended on ocular pigmentation. A dose of 0.1 mg did not cause any noticeable functional (Fig. 3) and structural damage (not shown here) either in albino or in pigmented eyes and could, therefore, be considered safe for both. his dose can be converted to a vitreal concentration of 68 //g/ml, assuming a vitreous volume of 1.47 ml for rabbits weighing 1.8 to 2.7 kg 36 and complete mixing of the drug in the vitreous. his concentration is similar to the levels used clinically. However, for every higher dose tested (0.3, 0.6, and 1.0 mg), the maximal degree of damage, assessed 1 week after injection from the b-wave ratio, was larger in albino than in pigmented rabbits (Fig. 3). herefore, permanent damage was considerably more apparent in albino than in pigmented rabbits. Approximately 3 months after injection of gentamicin, 7 out of 10 albino rabbits exhibited severe ERG deficit whereas only 3 out of 10 pigmented rabbits exhibited similar degrees of permanent functional damage (Fig. 5). hus, the safe dose of gentamicin is expected to be higher in pigmented eyes than in albino eyes. Similar differential susceptibility to gentamicin of albino and pigmented animals has been demonstrated in the cochlea of guinea pigs. 37 ' 38 he protection that melanin provided the rabbit retina from gentamicin toxicity could arise from the absorption of stray light, 22 from the absorption of free

9 Gentamicin-Induced Retinal oxicity 1883 radicals, 523 or from the binding of free gentamicin. 28 Our data suggested against the first two alternatives. Reducing the level of ambient illumination by keeping the rabbits in darkness or mixing gentamicin with a scavenger of free radicals did not protect the retina of albino rabbits from gentamicin-induced damage (Fig. 7). herefore, binding of free gentamicin by melanin was probably the mechanism by which ocular pigmentation partially protected the retina from gentamicin toxicity. hese observations indicate that gentamicin toxicity to the retina is mediated by the free, unbound drug only and that bound gentamicin does not affect the retina. Key Words electroretinography, gentamicin, melanin, rabbit, retina References 1. Doft BH, Barza M. Ceftazidime or amikacin: Choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis. Arch Ophthalmol. 1994; 112: Peyman GA, Paque J, Meisels HI, Bennet O. Postoperative endophthalmitis: A comparison of methods for treatment and prophylaxis with gentamicin. Ophthalmic Surg. 1975; 6: Mochizuki K, orisaki K, Kawasaki Y, et al. Retinal toxicity of antibiotics: Evaluation by electroretinogram. Doc Ophthalmol. 1988; 69: Zachari IG, Forster RK. Experimental intravitreal gentamicin. Am J Ophthalmol. 1976;82: Atkins WS, McPherson SD Jr. Intravitreal injection of ampicillin, cephaloridine, gentamicin, and tobramycin. Surg Forum. 1975; 26: Peyman GA, May DR, Ericson ES, Apple D. Intraocular injection of gentamycin: oxic effects of clearance. Arch Ophthalmol. 1974; 92: D'Amico DJ, Libert J, Kenyon KR, Hanninen LA, Caspers-Velu L. Retinal toxicity of intravitreal gentamicin: An electron microscopic study. Invest Ophthalmol VisSci. 1984; 25: D'Amico DJ, Caspers-Velu L, Libert J, Shanks EMS, Hanninen LA, Kenyon KR. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol. 1985; 100: Ling CH, Peyman GA, Raichard M. Electron microscopic study of toxicity of intravitreal injections of gentamicin in primates. Can J Ophthalmol. 1985;20:l Conway BP, abatabay CA, Campochiaro PA, D'Amico DJ, Hanninen LA, Kenyon KR. Gentamicin toxicity in the primate retina. Arch Ophthalmol. 1989; 107: Bennet O, Peyman GA. oxicity of intravitreal aminoglycosides in primates. Can J Ophthalmol. 1974;9: Brown GC, Eagle RC, Shakin EP, Gruber M, Arbizio W. Retinal toxicity of intravitreal gentamicin. Arch Ophthalmol. 1990; 108: McDonald HR, Schatz H, Allen AW, et al. Retinal toxicity secondary to intraocular gentamicin injection. Ophthalmology. 1986; 93: Snider JD, Cohen HB, Chenoweth RG. Acute ischemic retinopathy secondary to intraocular gentamicin. In: Ryan SJ, Dawson AK, Little HL, eds. Retinal Diseases. New York: Grune & Stratton; 1985: Conway BP, Campochiaro PA. Macular infarction after endophthalmius treated with vitrectomy and intravitreal gentamicin. Arch Ophthalmol. 1986; 104: Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis: he Aminoglycosides oxicity Study Group. Arch Ophthalmol. 1994; 112: alamo JH, D'Amico DJ, Hanninen LA, Kenyon KR, Shanks E. he influence of aphakia and vittectomy on experimental retinal toxicity of aminoglycoside antibiotics. Am J Ophthalmol. 1985; 100: so MOM. Retinal photic injury in normal and scorbutic monkeys. rans Am Ophthalmol Soc. 1987; 85: Noell WK. Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision Res. 1979;20: l. 20. de Lint PJ, van Norren D, oebosch AM. Effect of body temperature on threshold for retinal light damage. Invest Ophthalmol Vis Sci. 1992;33: O'Steen WK, Sweatt AJ, Brodish A. Effects of acute and chronic stress on the neural retina of young, midage, and aged Fischer-344 rats. Brain Res. 1987; 426: Rapp LM, Williams P. he role of ocular pigmentation in protecting against retinal light damage. Vision Res. 1980;20: Riley PA. Radicals in melanin biochemistry. Ann NY AcadSci. 1988;551: Knight KR, MacPhadyen K, Lepore DA, Kuwata N, Eadie PA, O'Brien BM. Enhancement of ischaemic rabbit skin flap survival with the antioxidant and free radical scavenger N-acetylcysteine. Clin Sci (Colch). 1991;81: Sala R, Moriggi E, <Jorvasce G, Morelli D. Protection by N-acetylcysteine against pulmonary endothelial cell damage induced by oxidant injury. Euro Respir J. 1993; 6: Loewenstein A, Zemel E, Lazar M, Perlman I. Druginduced retinal toxicity in albino rabbits: he effects of imipenem and aztreonam. Invest Ophthalmol Vis Sci. 1993; 34: Zemel E, Loewenstein A, Lazar M, Perlman I. he effects of myristyl gamma-picolinium chloride on the rabbit retina: Morphologic observations. Invest Ophthalmol Vis Sci. 1993; 34: Barza M, Baum J, Kane A. Inhibition of antibiotic activity in vitro by synthetic melanin. Antimicrob Agents Chemother. 1976; 10: Pu GA, Masland RH. Biochemical interruption of membrane phospholipid renewal in retinal photoreceptor cells. J Neurosd. 1984; 4:

10 1884 Investigative Ophthalmology & Visual Science, August 1995, Vol. 36, No Brewer NS. Antimicrobial agents: II: he aminoglycosides: Streptomycin, kanamycin, gentamycin, tobramycin, amikacin, neomycin. Mayo Clin Proc. 1977; 52: Moellering RC. In vitro antibacterial activity of the aminoglycoside antibiotics. Rev Infect Dis. 1983;5: S212-S Wang BM, Weiner ND, akada A, Schacht J. Characterization of aminoglycoside-lipid interactions and development of a refined model for ototoxicity testing. Biochem Pharmacol. 1984; 33: Schacht J. Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch Otorhinolaryngol. 1979; 224: Anderson RE, Maude MB, Kelleher PA. Metabolism of phosphatidylinositol in the frog retina. Biochim Biophys Ada. 1980; 620: Wetzel MG, O'Brien PJ. urnover of palmitate, arachidonate and glycerol in phosopholipids of rat rod outer segments. Exp Eye Res. 1986; 43: Green H, Sawyer JL, Leopold IH. Elaboration of bicarbonate ion in intraocular fluids: II: Vitreous humor, normal Values. AMA Arch Ophthalmol. 1957;57: Conlee JW, Gill SS, McCandless P, Creel DJ. Differential susceptibility to gentamicin ototoxicity between albino and pigmented guinea pigs. Hear Res. 1989;41: Conlee JW, Jensen RP, Parks N, Creel DJ. urn-specific and pigment dependent differences in the stria vascularis of normal and gentamicin-treated albino and pigmented guinea pigs. Hear Res. 1991; 55:57-69.

Reductions in Taurine Secondary to Photoreceptor Loss in Irish Setters with Rod-Cone Dysplasia

Reductions in Taurine Secondary to Photoreceptor Loss in Irish Setters with Rod-Cone Dysplasia Reductions in Taurine Secondary to Photoreceptor Loss in Irish Setters with Rod-Cone Dysplasia S. Y. Schmidr*t and G. D. Aguirre$ These studies show that onset of photoreceptor cell degeneration preceded

More information

Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis

Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis Br J Ophthalmol 2001;85:1289 1293 1289 The Rotterdam Eye Hospital I M Gan W H Beekhuis J C van Meurs Leiden University Medical Center, Department of Infectious Diseases J T van Dissel Leiden University

More information

Bradley D. Jett,*-f Harold G. Jensen,\ Rajeshwari V. Atkuri,X and Michael S. GilmoreW

Bradley D. Jett,*-f Harold G. Jensen,\ Rajeshwari V. Atkuri,X and Michael S. GilmoreW Evaluation of Therapeutic Measures for Treating Endophthalmitis Caused by Isogenic Toxin-Producing and Toxin-Nonproducing Enterococcus faecalis Strains Bradley D. Jett,*-f Harold G. Jensen,\ Rajeshwari

More information

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin

More information

Veterinary Ophthalmology

Veterinary Ophthalmology Veterinary Ophthalmology Eyelids Protect the eye Provides part of and spreads the tear film Regulates the amount of light that enters the eye Clears foreign material Third Eyelid Protects the cornea by

More information

Formoguanamine-induced blindness and photoperiodic responses in the Japanese quail, Coturnix coturnix japonica

Formoguanamine-induced blindness and photoperiodic responses in the Japanese quail, Coturnix coturnix japonica J. Biosci., Vol. 19, Number 4, October 1994, pp 479-484. Printed in India. Formoguanamine-induced blindness and photoperiodic responses in the Japanese quail, Coturnix coturnix japonica 1. Introduction

More information

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing rats. 2. RESPONSIBILITY Principal Investigators (PIs) and their research

More information

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing mice. 2. RESPONSIBILITY Principal Investigators (PIs) and their

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

THE VISUAL MECHANISMS OF TENEBRIO MOLITOR: VARIATIONS TAKING PLACE IN THE ERG OF PUPA AND ADULT DURING DEVELOPMENT

THE VISUAL MECHANISMS OF TENEBRIO MOLITOR: VARIATIONS TAKING PLACE IN THE ERG OF PUPA AND ADULT DURING DEVELOPMENT J. Exp. Biol. (1969), 51. 635-641 635 With 5 text-figures Printed in Great Britain THE VISUAL MECHANISMS OF TENEBRIO MOLITOR: VARIATIONS TAKING PLACE IN THE ERG OF PUPA AND ADULT DURING DEVELOPMENT BY

More information

F1 IN THE NAME OF GOD

F1 IN THE NAME OF GOD F1 IN THE NAME OF GOD Slide 1 F1 FEIKO.IR.SOFT; 2011/07/06 Lid Laceration Conjunctival Hemorrhage a) No therapy is necessary b) Usually resolve in 7-12 days. Subconjunctival Hemorrhage Corneal Abrasion

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

A. BACKGROUND INFORMATION

A. BACKGROUND INFORMATION Institutional Animal Care and Use Committee Title: Euthanasia Guidelines Document #: 006 Version #: 01 UNTHSC Approved by IACUC Date: October 22, 2013 A. BACKGROUND INFORMATION a. Euthanasia techniques

More information

ONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS

ONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS ONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS Contents 1. How to I calculate a gentamicin dose?... 2 2. How do I prescribe gentamicin on the cardex?... 2 3. Can I give

More information

How the eye sees. Properties of light. The light-gathering parts of the eye. 1. Properties of light. 2. The anatomy of the eye. 3.

How the eye sees. Properties of light. The light-gathering parts of the eye. 1. Properties of light. 2. The anatomy of the eye. 3. How the eye sees 1. Properties of light 2. The anatomy of the eye 3. Visual pigments 4. Color vision 1 Properties of light Light is made up of particles called photons Light travels as waves speed of light

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

Lens luxation when the lens gets wobbly

Lens luxation when the lens gets wobbly Lens luxation when the lens gets wobbly Introduction The lens what is it there for? The lens - anatomy Lens luxation What does that mean? Lens luxation - what to look out for? Lens luxation How can it

More information

Protein Synthesis Inhibitors

Protein Synthesis Inhibitors Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors

More information

SURGICAL (SURVIVAL) OOCYTE COLLECTION FROM XENOUS LAEVIS

SURGICAL (SURVIVAL) OOCYTE COLLECTION FROM XENOUS LAEVIS UBC Animal Care Guidelines SOP: ACC 2013 01 Surgical Oocyte Collection from Xenopus Laevis Submitted by: Shelly McErlane Last Date Revised: Date Approved: January 28, 2013 SURGICAL (SURVIVAL) OOCYTE COLLECTION

More information

The Guide for the Care and Use of Laboratory Animals, 8th Edition, November Euthanasia. pp

The Guide for the Care and Use of Laboratory Animals, 8th Edition, November Euthanasia. pp Euthanasia Policy IACUP Policy Effective Date: October 2015 I. Purpose This policy establishes the standards for euthanasia of laboratory animals at UCSF. This policy has been created to ensure that euthanasia

More information

Other Beta - lactam Antibiotics

Other Beta - lactam Antibiotics Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics

More information

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NUFLOR 300 mg/ml solution for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

Animal Studies Committee Policy Rodent Survival Surgery

Animal Studies Committee Policy Rodent Survival Surgery Animal Studies Committee Policy Rodent Survival Surgery ASC Policy: To optimize animal health and well-being, survival surgery in rodents must be performed using sterile instruments, surgical gloves, masks

More information

PROTOCOL FOR ANIMAL USE AND CARE

PROTOCOL FOR ANIMAL USE AND CARE PROTOCOL FOR ANIMAL USE AND CARE Score 1: Score 2: Total: 1. Contacts Primary Investigator Alternate contact Name Sandra Weisker Name Email sweisker@ucdavis.edu Email Dept Animal Science Dept Telephone

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amfipen LA 100 mg/ml suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Each ml contains:

More information

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: X New application Amendment

More information

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL 10%, solution for injection for cattle and swine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Marbofloxacin...100.0

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

SOP #: Page: 1 of 6 Rodent Analgesia

SOP #: Page: 1 of 6 Rodent Analgesia Comparative Medicine Page: 1 of 6 Rodent Analgesia The intent of this Standard Operating Procedure (SOP) is to describe commonly used analgesics provided to rodents housed at Comparative Medicine (CM).

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin

More information

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) (Note: many chemicals have been used at one time or another to combat bacterial disease in koi. We have attempted

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: X New application Amendment

More information

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbocare 20 mg/ml solution for injection for cattle and pigs (UK, IE, FR) Odimar 20 mg/ml solution for injection for cattle

More information

UNTHSC. Institutional Animal Care and Use Committee. Title: Euthanasia Guidelines. Document #: 006 Version #: 02

UNTHSC. Institutional Animal Care and Use Committee. Title: Euthanasia Guidelines. Document #: 006 Version #: 02 Institutional Animal Care and Use Committee Title: Euthanasia Guidelines Document #: 006 Version #: 02 UNTHSC Approved by IACUC Date: February 28, 2017 A. BACKGROUND INFORMATION a. According to 9 CFR part

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur... SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND

More information

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 1. NAME OF THE VETERINARY MEDICINAL PRODUCT FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

CO-ACTION. Prof.dr. J.W. Mouton. Note : some technical and all results slides were removed. JPIAMR JWM Paris JWM Paris 2017

CO-ACTION. Prof.dr. J.W. Mouton. Note : some technical and all results slides were removed. JPIAMR JWM Paris JWM Paris 2017 CO-ACTION Prof.dr. J.W. Mouton Note : some technical and all results slides were removed JPIAMR 1 Clinical Development of (old drug) combinations : essentials Potency of combination CoAction PK profiling

More information

Permanent Alterations in Muscarinic Receptors and Pupil Size Produced by Chronic Atropinization in Kittens

Permanent Alterations in Muscarinic Receptors and Pupil Size Produced by Chronic Atropinization in Kittens No. 2 Reports 239 Permanent Alterations in Muscarinic Receptors and Pupil Size Produced by Chronic Atropinization in Kittens Earl L. Smith III,* Dianna A. Redburn,f Ronald 5. Harwerrh,* and Gregory W.

More information

Pain Management in Racing Greyhounds

Pain Management in Racing Greyhounds Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a

More information

Nebcin0 in the treatment of experimental

Nebcin0 in the treatment of experimental Brit. J. Ophthal. (15) 5, 5 Nebcin in the treatment of experimental Pseudomonas keratitis RUBENS BELFORT, JR., GLBERT SMOLN, MASAO OKUMOTO, and HONG BOK KM From the Francis. Proctor Foundation for Research

More information

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests

More information

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Project Summary Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Principal Investigators: Mindy Brashears, Ph.D., Texas Tech University Guy

More information

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA

More information

Effects of Cage Stocking Density on Feeding Behaviors of Group-Housed Laying Hens

Effects of Cage Stocking Density on Feeding Behaviors of Group-Housed Laying Hens AS 651 ASL R2018 2005 Effects of Cage Stocking Density on Feeding Behaviors of Group-Housed Laying Hens R. N. Cook Iowa State University Hongwei Xin Iowa State University, hxin@iastate.edu Recommended

More information

Progressive Retinal Atrophy in the Abyssinian Cat

Progressive Retinal Atrophy in the Abyssinian Cat Progressive Retinal Atrophy in the Abyssinian Cat Electron Microscopy Kristina Narfstr6m*t and Sven Erik Nilsson* Seven adult Abyssinian cats at different stages of a recessively inherited retinal degenerative

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: New application Amendment

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AT, BE, BG, CY, CZ, DE, EE, EL, ES, FR, HR, HU, IE, IT, LT, LU, NL, PT, RO, SK, UK: Kelaprofen 100 mg/ml, solution for injection

More information

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

HOW XTC IMPROVED MINOXIDIL PENETRATION - 5 WAYS!

HOW XTC IMPROVED MINOXIDIL PENETRATION - 5 WAYS! HOW XTC IMPROVED MINOXIDIL PENETRATION - 5 WAYS! What Hinders Minoxidil from Working Well 1. Sebum from sebaceous gland blocks the hair follicle. 2. Minoxidil therefore, cannot penetrate through the sebum

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: New application Amendment

More information

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer

More information

ANTIBIOTICS IN PLASMA

ANTIBIOTICS IN PLASMA by LC/MS Code LC79010 (Daptomycin, Vancomycin, Streptomycin, Linezolid, Levofloxacin, Ciprofloxacin, Gentamicin, Amikacin, Teicoplanin) INTRODUCTION Technically it defines "antibiotic" a substance of natural

More information

CHAPTER3. Materials and methods

CHAPTER3. Materials and methods CHAPTER3 Materials and methods 3.1 Experimental Site and Housing The study was conducted at the Animal Production Institute of the Agricultural Research Council (ARC) Irene, in Gauteng Province of South

More information

Delayed-Onset Post-Keratoplasty Endophthalmitis Caused by Vancomycin-Resistant Enterococcus faecium

Delayed-Onset Post-Keratoplasty Endophthalmitis Caused by Vancomycin-Resistant Enterococcus faecium This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: X New application Amendment

More information

GUIDELINES FOR ANESTHESIA AND FORMULARIES

GUIDELINES FOR ANESTHESIA AND FORMULARIES GUIDELINES FOR ANESTHESIA AND FORMULARIES Anesthesia is the act of rendering the animal senseless to pain or discomfort and is required for surgical and other procedures. Criteria for choosing an anesthetic

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: New application Amendment

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ophtocycline 10 mg/g eye ointment for dogs, cats and horses (AT, BE, BG, CY, CZ, EL, ES, HR, HU, IE, IT, LU, NL,

More information

A New Advancement in Anesthesia. Your clear choice for induction.

A New Advancement in Anesthesia. Your clear choice for induction. A New Advancement in Anesthesia Your clear choice for induction. By Kirby Pasloske When using Alfaxan, patients should be continuously monitored, and facilities for maintenance of a patent airway, artificial

More information

Anesthetic regimens for mice, rats and guinea pigs

Anesthetic regimens for mice, rats and guinea pigs Comparative Medicine SOP #: 101. 01 Page: 1 of 10 Anesthetic regimens for mice, rats and guinea pigs The intent of the Standard Operating Procedure (SOP) is to describe commonly used methods to anaesthetize

More information

Ciprofloxacin Versus Tobramycin for the Treatment of Staphylococcal Keratitis

Ciprofloxacin Versus Tobramycin for the Treatment of Staphylococcal Keratitis Ciprofloxacin Versus Tobramycin for the Treatment of Staphylococcal Keratitis Michelle C. Callegan* Lee S. Engel,* James M. Hill,*"f and Richard J. O'Callaghan* Purpose. To compare the chemotherapeutic

More information

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed. Mouse Formulary The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.): Intraperitoneal (IP) doses should not exceed 80 ml/kg

More information

IACUC POLICY Rodent Survival Surgery

IACUC POLICY Rodent Survival Surgery BACKGROUND The University of Rhode Island s Institutional Animal Care and Use Committee (IACUC) is charged with ensuring that all surgical facilities and procedures meet the criteria set by the federal

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: New application Amendment

More information

Metacam 1.5 mg/ml oral suspension for dogs

Metacam 1.5 mg/ml oral suspension for dogs Metacam 1.5 mg/ml oral suspension for dogs Species:Dogs Therapeutic indication:pharmaceuticals: Neurological preparations: Analgesics, Other NSAIDs, Locomotor (including navicular and osteoarthritis) Active

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

Course Offerings: Associate of Applied Science Veterinary Technology. Course Number Name Credits

Course Offerings: Associate of Applied Science Veterinary Technology. Course Number Name Credits Course Offerings: Associate of Applied Science Veterinary Technology Course Number Name Credits Required Courses in Major: Fall Semester, First Year *VETT-101 Animal Health Careers 1-0-1 *VETT-102 Veterinary

More information

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique

More information

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: New application Amendment

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

European Public MRL assessment report (EPMAR)

European Public MRL assessment report (EPMAR) 18 March 2016 EMA/CVMP/619817/2015 Committee for Medicinal Products for Veterinary Use European Public MRL assessment report (EPMAR) Gentamicin (all mammalian food producing species and fin fish) On 3

More information

Interventions for children with ear discharge occurring at least two weeks following grommet(ventilation tube) insertion(review)

Interventions for children with ear discharge occurring at least two weeks following grommet(ventilation tube) insertion(review) Cochrane Database of Systematic Reviews Interventions for children with ear discharge occurring at least two weeks following grommet(ventilation tube) insertion(review) Venekamp RP, Javed F, van Dongen

More information

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys ANTIbMCROBIAL AGENTS AND CHEMOTHERAPY, June 197, p. 460-465 Copyright 197 American Society for Microbiology Vol. 1, No. 6 Printed in U.S.A. Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal

More information

THE UNIVERSITY OF ILLINOIS LIBRARY. cop. ACR1GUITURE

THE UNIVERSITY OF ILLINOIS LIBRARY. cop. ACR1GUITURE THE UNIVERSITY OF ILLINOIS LIBRARY cop. ACR1GUITURE C: BHECK FOR CIRCUL Effect of Fowler's Solution on Animals BY ELMER ROBERTS AND W. M. DAWSON UNIVERSITY OF ILLINOIS AGRICULTURAL EXPERIMENT STATION

More information

Dual Antibiotic Delivery from Chitosan Sponges Prevents In Vivo Polymicrobial Biofilm Infections

Dual Antibiotic Delivery from Chitosan Sponges Prevents In Vivo Polymicrobial Biofilm Infections Dual Antibiotic Delivery from Chitosan Sponges Prevents In Vivo Polymicrobial Biofilm Infections Ashley Parker, MS 1, James Smith, MS 1, Karen Beenken, PhD 2, Jessica Amber Jennings, PhD 3, Mark Smeltzer,

More information

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Parofor 70 mg/g powder for use in drinking water, milk or milk replacer for pre-ruminant cattle and pigs. 2. QUALITATIVE

More information

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Hydration Order for Reducing Risk of Radiocontrast Induced Nephrotoxicity Physician Order #683 In

More information

FREEDOM OF INFORMATION (FOI) SUMMARY

FREEDOM OF INFORMATION (FOI) SUMMARY Date of Approval: March 25, 2003 FREEDOM OF INFORMATION (FOI) SUMMARY Acepromazine Maleate Injection 10 mg/ml Tranquilizer for use in dogs, cats, and horses ANADA 200-319 Phoenix Scientific, Inc. 3915

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Selectan 300 mg/ml solution for injection for cattle and swine. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1 Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours

More information

Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle

Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle Treatment Study DRAXXIN vs. Nuflor July 2005 Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle Pfizer Animal Health, New York,

More information

Pre-natal construction of neural circuits (the highways are genetically specified):

Pre-natal construction of neural circuits (the highways are genetically specified): Modification of Brain Circuits as a Result of Experience Chapter 24, Purves et al. 4 th Ed. Pre-natal construction of neural circuits (the highways are genetically specified): (1/6/2010) Mona Buhusi Postnatal

More information

Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010

Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010 Biochrom AG s antibiotics solutions: Up-to to-date overview regarding of action, performance and working concentration Biochrom AG Information, November 19, 2010 Cell culture media allow not only cells

More information

Antimicrobial Selection to Combat Resistance

Antimicrobial Selection to Combat Resistance Antimicrobial Selection to Combat Resistance (Dead Bugs Don t Mutate!) Shelley C Rankin PhD Associate Professor CE Microbiology Head of Diagnostic Services & Chief of Clinical Microbiology Ryan Veterinary

More information

Principles of Antimicrobial Therapy

Principles of Antimicrobial Therapy Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1

More information

Considerations in antimicrobial prescribing Perspective: drug resistance

Considerations in antimicrobial prescribing Perspective: drug resistance Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tilmovet 250 mg/ml Concentrate for Oral Solution (BE, BG, CZ, EL, HU, IE, NL, PL, RO, UK) for pigs, chickens, turkeys and

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats (UK, IE, FR) Floxadil 50 mg/ml Solution for Injection

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOXYPRIM 40% soluble powder 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Doxycycline hyclate 400.0 mg Excipients:

More information

Role of Moxifloxacin in Bacterial Keratitis

Role of Moxifloxacin in Bacterial Keratitis Original Article Role of Moxifloxacin in Bacterial Keratitis Aamna Jabran, Aurengzeb Sheikh, Syed Ali Haider, Zia-ud-din Shaikh Pak J Ophthalmol 29, Vol. 25 No. 2.................................................................................

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Cefenil 50 mg/ml Powder and Solvent for Solution for Injection for and. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Powder vial

More information

DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS

DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS OBJECTIVE: This policy is to ensure that appropriate provisions

More information

Perspectives for Retinitis Pigmentosa

Perspectives for Retinitis Pigmentosa Perspectives for Retinitis Pigmentosa The subretinal implant Information for patients A Window of Hope Fifteen years of research and development have shown us that although your sight may be deteriorating

More information